HIMS
Not rated
No published distribution safety rating is available.
Security Comparison
A head-to-head comparison of Hims & Hers Health Inc. and GraniteShares YieldBOOST HIMS ETF covering yield, cost, risk, and income potential.
Updated November 17, 2026
How these figures are calculated: methodology.
Compare the same available dates. Add a ticker or benchmark below; these controls change the chart only. The snapshot and article describe the original comparison.
Interactive history loads here. The snapshot and period returns remain available when chart history cannot be loaded.
An estimate of distribution reliability, not price or principal safety, a probability, or a guarantee. Score methodology.
Not rated
No published distribution safety rating is available.
High risk
Limited data
Score snapshot as of .
| Metric | ||
|---|---|---|
| Full name | Hims & Hers Health Inc. | GraniteShares YieldBOOST HIMS ETF |
| Issuer | — | GraniteShares |
| Last Close | $17.55 as of November 17, 2026 | $4.54 as of November 17, 2026 |
| Distribution rate | — | 83.19% |
| Trailing 12-month yield | — | 206.51% |
| 30-day SEC yield | — | 0.64% |
| Distribution Safety Score™ | — | 15 |
| Safety-Adjusted Yield | — | 12.48% |
| Expense ratio | — | 1.07% |
| AUM | — | $853,442 |
| Distribution frequency | None | Weekly |
| Underlying index | — | Hims & Hers Health (HIMS) |
| Objective | — | Seeks to provide weekly income through selling near-the-money put spreads on leveraged ETFs linked to Hims & Hers Health, with built-in risk control through the put spread collar structure. |
| Asset class | Equity | Equity |
| Inception date | N/A | 12/02/2025 |
| Beta | 2.502 | — |
| Last dividend | — | $0.07255 payable 11/17/2026 |
| Ex-dividend date | — | 11/13/2026 |
100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year.
HIMS has outpaced HMYY over the year to date, posting a -45.95% total return against -46.52%. HMYY has been the steadier holding, though — annualized volatility of 27.2% against 91.6% for HIMS. Figures are total returns: price change plus every distribution reinvested.
| Symbol | YTD cumulative | Since Dec 2025 | Volatility | Sharpe | Sortino | Max drawdown |
|---|---|---|---|---|---|---|
| HIMS | -45.95% | -51.67% | 91.6% | -0.88 | -1.24 | -63.7% |
| HMYY | -46.52% | -54.24% | 27.2% | -3.16 | -3.76 | -57.2% |
Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of November 17, 2026. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year. “Since Dec 2025” measures every fund from December 2, 2025 — the start of shared available history — so all funds share one comparison window. Volatility is the annualized standard deviation of daily total returns over the shared window since Dec 2025. Sharpe and Sortino divide the annualized return in excess of the risk-free rate by, respectively, that volatility and the downside deviation (both over the shared window since Dec 2025) — higher is better. Max drawdown is the largest peak-to-trough total-return decline over the same window — shallower is better.
| Metric | HIMS | HMYY |
|---|---|---|
| Forward distribution rate | — | 83.19% |
| Trailing 12-month yield | — | 206.51% |
| 30-day SEC yield | — | 0.64% |
| Return of capital | — | 96.79% |
Total return (price change plus reinvested distributions) is the Total returns section above. Return of capital is the share of a recent distribution that was not income. A 30-day SEC yield can sit far from the headline distribution rate; both numbers are the fund's own published fields.
HIMS (Hims & Hers Health Inc.) has no distribution rate on file and its distribution frequency is None. HIMS is not a payer. The blank yield is not a zero yield.
Projections assume the current yield and share price remain constant. Actual results will vary.
Bottom lineChoose HIMS if you want direct ownership of the underlying business, with no fund wrapper or management fee. Choose HMYY if you want to maximize current income — roughly 83.19%, generated by selling options premium. There's no free lunch: HMYY's payout comes from selling puts, which adds losses when the market falls and can erode the share price over time, while HIMS has no option overlay.
Read this before the income numbers below: the strategy mechanics on this page shape what those payouts can cost you.
Learn the mechanics: Return of capital, explained · NAV erosion, explained
See how much monthly income a hypothetical investment would generate in each security at current yields.
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
GraniteShares is known for offering specialized ETF strategies that extend beyond traditional equity and bond investing, particularly through structured products and income-focused solutions. GraniteShares targets investors seeking alternative income generation methods and commodity access, with popular tickers like AHD, CRY, and FBL representing their diverse approach to yield enhancement and alternative asset classes.
See our curated list of related YouTube videos on HMYY.
HIMS (Hims & Hers Health Inc.) is a stock, while HMYY (GraniteShares YieldBOOST HIMS ETF) is an ETF — their trading structures differ.
HMYY currently shows a 83.19% distribution yield. HIMS has not yet established a full distribution history, so a comparable yield figure is not available.
On a $10,000 investment at current distribution rates, HIMS has no reported distribution yield yet, so a cash estimate is not available, while HMYY would pay about $8,319.00 a year (about $159.98 per weekly distribution).
HMYY charges a 1.07% expense ratio — roughly $1,070 over 10 years on $10,000 (simplified, not compounded). HIMS is a stock, not a fund, so it charges no expense ratio.
HIMS is a stock, while HMYY tracks Hims & Hers Health (HIMS) with a leverage approach.
HIMS (Hims & Hers Health Inc.) is a stock. HMYY is managed by GraniteShares (launched 12/02/2025) with $853,442 in assets.
HMYY currently reports a distribution yield, while HIMS has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.
HIMS (Hims & Hers Health Inc.) is a stock, while HMYY (GraniteShares YieldBOOST HIMS ETF) tracks Hims & Hers Health (HIMS) with a leverage approach. HMYY is issued by GraniteShares.
Yes — nothing prevents holding both. Whether the combination actually diversifies depends on how much the underlying exposures overlap, which isn't fully measurable from the data on this page; review each security's holdings, sector, and strategy before treating them as complementary.
HMYY charges a 1.07% expense ratio. HIMS is a stock, not a fund, so it charges no expense ratio.
At current distribution rates, HIMS does not pay distributions, so there is no cash income to estimate. $10,000 in HMYY would pay about $8,319.00 a year (about $159.98 per weekly distribution).
HIMS has outpaced HMYY over the year to date, posting a -45.95% total return against -46.52%. HMYY has been the steadier holding, though — annualized volatility of 27.2% against 91.6% for HIMS. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.
Generated November 7, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
HMYY uses options mechanics that HIMS does not. HMYY's $853,442 asset base reflects its very recent launch on 12/02/2025, whereas HIMS has traded since 09/13/2019. HIMS trades at $17.55, while HMYY's share price sits at $4.54.
HIMS: Fits investors who believe in the long-term growth trajectory of telehealth and digital prescription services and are willing to accept substantial price swings without current income. Suits those seeking capital appreciation rather than regular distributions.
HMYY: Fits income-focused investors seeking weekly cash flow from a concentrated, options-based strategy and who actively monitor leverage and put-spread mechanics. Designed for investors with high risk tolerance who understand that the elevated distribution rate depends on ongoing premium collection and the put spreads remaining profitable.
HMYY's yield is contingent on its novel put-spread strategy continuing to generate premium, and its extremely recent inception means the fund has not weathered a market downturn or volatility spike. Past performance does not predict future results, and the sustainability of HMYY's distributions has not been tested across a full market cycle.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
The metrics behind this comparison, explained in the Academy.
These comparisons follow the Dividend Vision methodology.